Abbott Labs swings to profit;
Abbott Laboratories announced that it swung to a profit in the fourth quarter from year-earlier results that were reduced by charges for acquisition costs.
Abbott Laboratories announced plans to split into two publicly traded companies -- one in diversified medical products and the other in research-based pharmaceuticals, marking a significant change in the company's 123-year history.